Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
14.20
-0.29 (-2.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
Amylyx Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,559 | 257 | 994 | 2,448 | - | - | |
| Market Cap Growth | 338.80% | -74.11% | -59.40% | - | - | - | |
| Enterprise Value | 1,221 | 26 | 644 | 2,292 | - | - | |
| Last Close Price | 14.20 | 3.78 | 14.72 | 36.95 | - | - | |
| PE Ratio | - | - | 20.17 | - | - | - | |
| Forward PE | - | - | 16.68 | - | - | - | |
| PS Ratio | -2345.02 | 2.95 | 2.61 | 110.13 | - | - | |
| PB Ratio | 4.69 | 1.56 | 2.29 | 7.19 | - | - | |
| P/TBV Ratio | 4.70 | 1.56 | 2.29 | 7.19 | - | - | |
| P/FCF Ratio | - | - | 93.08 | - | - | - | |
| P/OCF Ratio | - | - | 83.39 | - | - | - | |
| EV/Sales Ratio | - | 0.29 | 1.69 | 103.12 | - | - | |
| EV/EBITDA Ratio | - | - | 16.13 | - | - | - | |
| EV/EBIT Ratio | - | - | 16.59 | - | - | - | |
| EV/FCF Ratio | - | - | 60.27 | - | - | - | |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.02 | - | 0.27 | |
| Debt / EBITDA Ratio | - | - | 0.10 | - | - | - | |
| Debt / FCF Ratio | - | - | 0.40 | - | - | - | |
| Asset Turnover | - | 0.25 | 0.84 | 0.09 | 0.01 | 0.08 | |
| Inventory Turnover | - | - | 6.39 | - | - | - | |
| Quick Ratio | 13.35 | 6.23 | 5.02 | 7.78 | 5.53 | 1.76 | |
| Current Ratio | 13.70 | 6.67 | 5.66 | 8.20 | 6.03 | 1.86 | |
| Return on Equity (ROE) | -56.53% | -100.88% | 12.73% | -92.53% | -188.05% | - | |
| Return on Assets (ROA) | -39.44% | -51.31% | 5.34% | -50.63% | -86.34% | -281.44% | |
| Return on Capital (ROIC) | -45.08% | -60.36% | 6.18% | -57.85% | -108.86% | -1215.56% | |
| Return on Capital Employed (ROCE) | -57.40% | -176.70% | 8.90% | -58.40% | -93.70% | -575.50% | |
| Earnings Yield | -9.57% | -117.25% | 4.96% | -8.10% | - | - | |
| FCF Yield | -12.23% | -79.27% | 1.07% | -7.45% | - | - | |
| Buyback Yield / Dilution | -24.05% | 2.64% | -19.65% | -788.13% | -8.37% | -3.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.